Holen Sie sich die Stockscreener-App
11.93
0.45%
-0.0541
Handel nachbörslich:
11.77
-0.1628
-1.36%
Schlusskurs vom Vortag:
$11.99
Offen:
$12.2
24-Stunden-Volumen:
6,686
Relative Volume:
0.28
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-6.03%
1M Leistung:
+60.78%
6M Leistung:
-7.50%
1J Leistung:
-19.91%
1-Tages-Spanne:
$11.85
$12.20
1-Wochen-Bereich:
$11.85
$12.62
52-Wochen-Spanne:
$7.14
$17.00
Advisorshares Psychedelics Etf Stock (PSIL) Company Profile
Firmenname
Advisorshares Psychedelics Etf
Sektor
Branche
Telefon
-
Adresse
-
Advisorshares Psychedelics Etf Aktie (PSIL) Neueste Nachrichten
5 Best-Performing ETFs of October - Nasdaq
(PSIL) Trading Signals - Stock Traders Daily
Trackinsight ETF data from 14th to 18th October, 2024 - ETF Express
DRUG Enhances Buzz for Psilocybin, Psychedelic ETFs - TradingView
Learn to Evaluate (PSIL) using the Charts - Stock Traders Daily
Reverse split for AdvisorShares Psychedelic ETF starts today - Green Market Report
AdvisorShares Announces Reverse Split of ETF - PR Newswire
Cannabis And Psychedelics Industries: Summer's Over, Where Are We? - Benzinga
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 1% - Defense World
VIXY Jumped 7.3% Last Week - Yahoo Finance
Best Psychedelic ETFs - Benzinga
Time for Healthcare ETFs? - Yahoo Finance
How to Invest in the Semiconductor Value Chain with These ETFs - The Globe and Mail
Advisorshares Psychedelics ETF (PSIL-A) QuotePress Release - The Globe and Mail
TD Asset Management: The Future of Quantitative Investing - The Globe and Mail
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading 0.9% Higher - Defense World
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment - Markets Insider
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Holdings Increased by Spire Wealth Management - Defense World
Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSD - BNN Bloomberg
ETF Issuer: Bristol Gate Capital Partners Inc. - The Globe and Mail
The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail
A New Horizon: Horizons ETF Management Canada to rebrand as Global X - The Globe and Mail
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance’ - Bloomberg
Mental Health Mavericks: 3 Stocks Changing the Game - Yahoo Finance
Viridian Capital finds psychedelic stocks typically trade at 3x book - Green Market Report
Psychedelic Funding & Public Markets in 2023 - Psychedelic Alpha
Psychedelics Are Going Mainstream. Investing in Them Hasn’t. - The Wall Street Journal
11 Most Promising Psychedelic Stocks According to Hedge Funds - Yahoo Finance
MAPS PBC submits first-ever NDA for MDMA-assisted PTSD therapy - Proactive Investors UK
New Report Predicts Psychedelic Industry Shakeout - Green Market Report
Will Psychedelics Companies Win The Mental Health Boom? - Finimize
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - Benzinga
How to Invest in Psychedelics - Investing News Network
'We’re in the shakeout stage': The psychedelics boom in healthcare has lost its buzz as some companies struggle to make payroll - Fortune
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More - Benzinga
Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More - Benzinga
AdvisorShares' Noah Hamman: "It Could Be a Rough, Rough Year" - Nasdaq
PSIL: When Investing In Psychedelic Firms, ETFs Are The Safer Route (NYSEARCA:PSIL) - Seeking Alpha
Options Listed for the AdvisorShares MSOS 2x Daily ETF (Ticker: MSOX) - PR Newswire
The 7 Most Promising Psychedelic Stocks to Buy in February - InvestorPlace
Psychedelics in the Public Markets: 2022 - Psychedelic Alpha
Worst Performing ETFs of 2022 - etf.com
Math Over Myth: Positive Technical Divergences in the Psychedelic Sector - Psychedelic Spotlight
Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3 - Psychedelic Spotlight
Psychedelic Stocks: ARK Invest and the Reverse Midas Touch - Psychedelic Spotlight
7 Psychedelics Stocks to Buy for a Big Drug Boom - Yahoo Finance
AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2x Daily ETF (Ticker: MSOX) - PR Newswire
The Growth Potential Of Psychedelics Stocks And ETFs - Seeking Alpha
The Four Psychedelics ETFs Capturing Investor Attention - Psychedelic Spotlight
Understanding 3 Risks of Investing in Psychedelic Stocks - Psychedelic Spotlight
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Finanzdaten der Advisorshares Psychedelics Etf-Aktie (PSIL)
Es liegen keine Finanzdaten für Advisorshares Psychedelics Etf (PSIL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):